Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QX6W
|
|||
| Drug Name |
Benzotriazole derivative 1
|
|||
| Synonyms |
PMID26560530-Compound-40
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
Universit de Montral
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H20N4O3
|
|||
| Canonical SMILES |
CC(C)(C)OC(=O)NC1=CC=C(C=C1)C=CC(=O)N2C3=CC=CC=C3N=N2
|
|||
| InChI |
1S/C20H20N4O3/c1-20(2,3)27-19(26)21-15-11-8-14(9-12-15)10-13-18(25)24-17-7-5-4-6-16(17)22-23-24/h4-13H,1-3H3,(H,21,26)/b13-10+
|
|||
| InChIKey |
HXHBNXDLCDLAKO-JLHYYAGUSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tissue transglutaminase (TG2) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Tissue transglutaminase (TG2) | Target's Patent Info | [1] | |
| KEGG Pathway | Huntington's disease | |||
| Pathway Interaction Database | Beta1 integrin cell surface interactions | |||
| Thromboxane A2 receptor signaling | ||||
| Alpha9 beta1 integrin signaling events | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Transglutaminase inhibitors: a patent review.Expert Opin Ther Pat. 2016;26(1):49-63. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.